Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Guozheng Ding"'
Autor:
Lei Fang, Guozheng Ding, Muzi Wang, Yuanzi Ye, Xuebo Yan, Peishan Ding, Jiong Wang, Yanbei Zhang
Publikováno v:
Medicine. 101(34)
Anaplastic lymphoma kinase (ALK) gene fusion, an important driver gene alteration leading to the development of lung cancer, occurs in 5% of nonsmall cell lung cancer (NSCLC) cases in China. In addition to echinoderm microtubule-associated protein-li
Autor:
Danqing Liu, Guozheng Ding
Publikováno v:
Medicine
Nonsmall cell lung cancer (NSCLC) is the most common type of lung cancer. This study aimed to categorize the microvessels in advanced NSCLC and determine the relationship between intratumoral microvascular density (MVD) and the efficacy of anlotinib
Autor:
Wenjing Cheng, Guozheng Ding
Background: At present, there is a higher complication rate after treatment of femoral neck fractures with three parallel hollow nails (PHN) in the young Pauwels type Ⅲ femoral neck fractures.For better effect,F-shape hollow nails(FHN) is used to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d6bff132f7d78b9ba6ee63ef9f9bd1a
https://doi.org/10.21203/rs.3.rs-592204/v1
https://doi.org/10.21203/rs.3.rs-592204/v1
Autor:
Guozheng Ding, Wenjing Cheng
Background: The value of early postoperative radiographs is generally questioned after volar plate fixation(VLP) for distal radius fractures(DRFs). The purpose of this study was to evaluate the utility of early routine radiographs following volar pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9010a5860aaf817a7ac7d9905f2908eb
https://doi.org/10.21203/rs.3.rs-141480/v1
https://doi.org/10.21203/rs.3.rs-141480/v1
Autor:
Jianlin Xu1, Guozheng Ding2, Xueyan Zhang1, Bo Jin1, Yuqing Lou1, Yanwei Zhang1, Huiming Wang1, Dan Wu3, Baohui Han1 xkyyhan@gmail.com
Publikováno v:
OncoTargets & Therapy. Oct2016, Vol. 9, p6479-6484. 6p.
Autor:
Yuqing Lou, Yanwei Zhang, H. Wang, Jianlin Xu, Xueyan Zhang, Guozheng Ding, Bo Jin, Dan Wu, Baohui Han
Publikováno v:
OncoTargets and Therapy. 9:6479-6484
Jianlin Xu,1,* Guozheng Ding,2,* Xueyan Zhang,1 Bo Jin,1 Yuqing Lou,1 Yanwei Zhang,1 Huiming Wang,1 Dan Wu,3 Baohui Han1 1Department of Pulmonary, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China; 2Depart
Autor:
Huimin Wang, Yuqing Lou, Guozheng Ding, Xueyan Zhang, Yanwei Zhang, Baohui Han, Haitang Yang, Bo Jin, Jianlin Xu
Publikováno v:
Oncotarget
// Jianlin Xu 1, * , Xueyan Zhang 1, * , Haitang Yang 2 , Guozheng Ding 3 , Bo Jin 1 , Yuqing Lou 1 , Yanwei Zhang 1 , Huimin Wang 1 , Baohui Han 1 1 Department of Pulmonary, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China 2 De
Autor:
Jianlin, Xu, Guozheng, Ding, Xueyan, Zhang, Bo, Jin, Yuqing, Lou, Yanwei, Zhang, Huiming, Wang, Dan, Wu, Baohui, Han
Publikováno v:
OncoTargets and therapy
Introduction Clinical evidence comparing chemotherapy and tyrosine kinase inhibitors (TKIs) as second-line therapy for epidermal growth factor receptor (EGFR) wild-type non-small-cell lung cancer (NSCLC) are conflicting. Methods We retrospectively re